KINGSEMI Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

KINGSEMI şirketinin toplam hissedar öz sermayesi CN¥2.5B ve toplam borcu CN¥1.2B olup, bu da borç-öz sermaye oranını 46.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥5.0B ve CN¥2.5B dir. KINGSEMI 'in FAVÖK'ü CN¥108.0M faiz karşılama oranı 11.2 dur. Şirketin CN¥1.2B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

46.9%

Borç/özkaynak oranı

CN¥1.19b

Borç

Faiz karşılama oranı	11.2x
Nakit	CN¥1.16b
Eşitlik	CN¥2.53b
Toplam yükümlülükler	CN¥2.49b
Toplam varlıklar	CN¥5.02b

Son finansal sağlık güncellemeleri

Recent updates

These 4 Measures Indicate That KINGSEMI (SHSE:688037) Is Using Debt Extensively

Nov 14

KINGSEMI Co., Ltd. (SHSE:688037) Not Flying Under The Radar

Sep 27

KINGSEMI (SHSE:688037) Could Be Struggling To Allocate Capital

Aug 16

KINGSEMI (SHSE:688037) Has A Somewhat Strained Balance Sheet

Jul 26

Earnings Tell The Story For KINGSEMI Co., Ltd. (SHSE:688037) As Its Stock Soars 27%

Jun 13

KINGSEMI's (SHSE:688037) Problems Go Beyond Weak Profit

May 03

KINGSEMI (SHSE:688037) Is Doing The Right Things To Multiply Its Share Price

Apr 11

Does KINGSEMI (SHSE:688037) Have A Healthy Balance Sheet?

Mar 19

KINGSEMI Co., Ltd.'s (SHSE:688037) P/E Is Still On The Mark Following 26% Share Price Bounce

Mar 01

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 688037 'nin kısa vadeli varlıkları ( CN¥3.8B ) kısa vadeli yükümlülüklerini ( CN¥1.4B ) aşıyor.

Uzun Vadeli Yükümlülükler: 688037 şirketinin kısa vadeli varlıkları ( CN¥3.8B ) uzun vadeli yükümlülüklerini ( CN¥1.1B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 688037 'nin net borç/öz sermaye oranı ( 1.3% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 688037 şirketinin borç/öz sermaye oranı son 5 yılda 0% seviyesinden 46.9% seviyesine yükseldi.

Borç Kapsamı: 688037 'nin borcu işletme nakit akışı ( 18.2% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: 688037 'in borcuna ilişkin faiz ödemeleri EBIT ( 11.2 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

KINGSEMI Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

These 4 Measures Indicate That KINGSEMI (SHSE:688037) Is Using Debt Extensively

KINGSEMI (SHSE:688037) Has A Somewhat Strained Balance Sheet

Does KINGSEMI (SHSE:688037) Have A Healthy Balance Sheet?

Recent updates

Consensus revenue estimates increase by 11%, EPS downgraded

These 4 Measures Indicate That KINGSEMI (SHSE:688037) Is Using Debt Extensively

Consensus revenue estimates decrease by 26%

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates increase by 15%, revenue downgraded

KINGSEMI Co., Ltd. to Report Q3, 2024 Results on Oct 23, 2024

KINGSEMI Co., Ltd. (SHSE:688037) Not Flying Under The Radar

New minor risk - Profit margin trend

KINGSEMI (SHSE:688037) Could Be Struggling To Allocate Capital

KINGSEMI (SHSE:688037) Has A Somewhat Strained Balance Sheet

Price target decreased by 12% to CN¥79.49

Price target decreased by 12% to CN¥79.49

Consensus EPS estimates fall by 14%

Investor sentiment deteriorates as stock falls 25%

KINGSEMI Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Earnings Tell The Story For KINGSEMI Co., Ltd. (SHSE:688037) As Its Stock Soars 27%

KINGSEMI Co., Ltd., Annual General Meeting, Jun 17, 2024

Price target decreased by 20% to CN¥130

KINGSEMI's (SHSE:688037) Problems Go Beyond Weak Profit

First quarter 2024 earnings: EPS and revenues miss analyst expectations

KINGSEMI (SHSE:688037) Is Doing The Right Things To Multiply Its Share Price

KINGSEMI Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Does KINGSEMI (SHSE:688037) Have A Healthy Balance Sheet?

KINGSEMI Co., Ltd.'s (SHSE:688037) P/E Is Still On The Mark Following 26% Share Price Bounce

Full year 2023 earnings: EPS and revenues miss analyst expectations

KINGSEMI Co., Ltd. (SHSE:688037) announces an Equity Buyback for CNY 20 million worth of its shares.

Investor sentiment deteriorates as stock falls 15%

KINGSEMI Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased by 13% to CN¥174

New major risk - Earnings quality

Investor sentiment deteriorates as stock falls 15%

KINGSEMI Co., Ltd. to Report First Half, 2023 Results on Aug 29, 2023

Price target increased by 8.4% to CN¥206

Price target increased by 8.6% to CN¥281

Price target increased by 7.5% to CN¥258

Price target increased by 7.9% to CN¥258

Consensus revenue estimates increase by 11%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased by 8.5% to CN¥240

Price target increased by 12% to CN¥221

Price target increased to CN¥205

Less than half of directors are independent

Price target increased to CN¥205

Consensus EPS estimates increase by 38%

Third quarter 2022 earnings released: EPS: CN¥0.80 (vs CN¥0.21 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.33 in 2Q 2021)

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Less than half of directors are independent

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2021 earnings released: EPS CN¥0.33 (vs CN¥0.16 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.08 (vs CN¥0.09 loss in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.58 (vs CN¥0.46 in FY 2019)

New 90-day low: CN¥82.45

KINGSEMI Co., Ltd. to Report Fiscal Year 2020 Results on Mar 20, 2021

New 90-day low: CN¥85.44

New 90-day low: CN¥93.62

New 90-day low: CN¥99.98

KINGSEMI Co., Ltd. to Report First Half, 2020 Results on Aug 27, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin